Principal Investigator
Shukui Qin
NanJing PLA 81 Hospital
Total Trials
1
As PI
1
Completed
0
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
DRUG(2)
HUACHANSU PIAN
1 trial
phase_3
beijing-shenogen-biomedical-co-ltdIcaritin
1 trial
phase_3
beijing-shenogen-biomedical-co-ltd2 unique interventions1 categories
Analytics
Trial Phases
Phase 31
Trial Status
Other1
Role Distribution
Principal Investigator1
PI Rate100%
Activity Timeline
Clinical Trials (1)
The Phase III Study of Icaritin Versus HUACHANSU PIAN in Hepatocellular Carcinoma Subjects
Advanced HBV-Related Hepatocellular Carcinoma (HCC)
PrincipalinvestigatorStart date: 2017-09-08
Research Network
Collaboration Network
4 collaborators·3 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
NanJing PLA 81 Hospital
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
1 similar investigators found
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
The Phase III Study of Icaritin Versus HUACHANSU PIAN in Hepatocellular Carcinoma Subjects
Advanced HBV-Related Hepatocellular Carcinoma (HCC)
All 1 trials loaded